Coeptis Therapeutics Holdings, Inc. (COEPW) Institutional Ownership

Based on Q1 2026 13F filings, institutional ownership of Coeptis Therapeutics Holdings, Inc. stands at 8.2%, held across 10 reporting institutions.

RIVERNORTH CAPITAL MANAGEMENT, LLC is the largest reported institutional holder of COEPW, with approximately 147,970 shares worth $0.00B as of Q1 2026.

Yes — 1 widely-followed marquee investor appear among the top 25 institutional holders of COEPW, including TWO SIGMA SECURITIES, LLC.

Our composite Smart Money Score for COEPW is 52 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.

2 institutions opened new positions in COEPW during Q1 2026, while 3 fully exited. 6 added to existing positions and 0 trimmed.

COEPW institutional ownership rose by 2.54 percentage points quarter-over-quarter, with a net change of -1 holders.

The top 10 institutions account for 100.0% of all reported 13F value in COEPW, and the top 25 account for 100.0%.

All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.